Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F22%3A43923338" target="_blank" >RIV/00064173:_____/22:43923338 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/22:43923338
Result on the web
<a href="https://doi.org/10.1093/eurheartjsupp/suac004" target="_blank" >https://doi.org/10.1093/eurheartjsupp/suac004</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/eurheartjsupp/suac004" target="_blank" >10.1093/eurheartjsupp/suac004</a>
Alternative languages
Result language
angličtina
Original language name
Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
Original language description
Transcatheter aortic valve implantation (TAVI) has become a high-volume procedure with increasing demands on hospital resources. Local anaesthesia with sedation supervised by an anaesthesiology team is the current standard of care. We aimed to describe our experience with a simplified, nurse-led sedation (NLS) protocol. This study enrolled 128 consecutive patients who underwent transfemoral TAVI with self-expandable Evolut R prosthesis between November 2019 and April 2021. Operators selected 50% of patients for NLS based on the clinical expectation of lower risk of procedural difficulties. Nurse-led sedation protocol demanded only mild to moderate levels of sedation. The clinical outcomes were determined from the local TAVI registry and the national mortality database. Baseline patient characteristics were similar in the NLS (n = 64) and anaesthesiologist-led sedation (ALS) (n = 64) groups except higher prevalence of diabetes mellitus (48.4% vs. 31.3%, P = 0.035) and peripheral vascular disease (20.3% vs. 7.8%, P = 0.036) in the ALS group. There was a trend for the larger prostheses used in the ALS group (P = 0.058). The procedural results did not differ, and coronary care team backup was rarely needed in the NLS group (6% of patients). The in-hospital outcomes were identical from both clinical and echocardiography perspectives, and 30-day mortality was low in both groups (1.5%). For the NLS group, preparation in the catheterization laboratory was quicker by 6.4 min (P = 0.01), and intensive care unit stay was shorter (2.03 vs. 3.48 days, P = 0.001). In conclusion, the NLS for the selected transfemoral TAVI population seems safe.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/EF16_026%2F0008388" target="_blank" >EF16_026/0008388: Interventional treatment of life-threatening cardiovascular diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Heart Journal: Supplements
ISSN
1520-765X
e-ISSN
1554-2815
Volume of the periodical
24
Issue of the periodical within the volume
Suppl. B
Country of publishing house
GB - UNITED KINGDOM
Number of pages
5
Pages from-to
"B23"-"B27"
UT code for WoS article
000780488200006
EID of the result in the Scopus database
2-s2.0-85143713198